IP Library Patent Application 15047112
Patent Application
App. No. 15/047,112

PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND BIOBASED COMPOUNDS THAT INCLUDE ETHYLENEOLYSIS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/047,112
Abstract

Provided herein are compounds prepared from processes that include ethyleneolysis. Exemplary processes include the preparation of terminally-unsaturated fatty acid reactant by ethyleneolysis catalyzed by a cyclic alkyl amino carbene ruthenium complex. The subsequent oligomerization of terminally-unsaturated fatty acid reatants provides estolide compounds, as exemplified by the process set forth below:

Claims (51)

1 - 201 . (canceled)

202 . A process comprising

providing a terminally-unsaturated fatty acid reactant derived from a process that includes contacting one or more unsaturated fatty acid substrates having at least one internal site of unsaturation with a cyclic alkyl amino carbene ruthenium complex in the presence of ethylene; and

reacting the terminally-unsaturated fatty acid reactant with a second fatty acid reactant to provide at least one compound.

203 . (canceled)

204 . (canceled)

205 . (canceled)

206 . The process according to claim 202 , wherein the one or more unsaturated fatty acid substrate comprises a triglyceride having at least one oleic acid residue.

207 . (canceled)

208 . (canceled)

209 . The process according to claim 202 , wherein the terminally-unsaturated fatty acid reactant comprises 9-decenoic acid.

210 . The process according to claim 202 , wherein the second fatty acid reactant comprises at least one of a saturated fatty acid or an unsaturated fatty acid.

211 . (canceled)

212 . (canceled)

213 . The process according to claim 202 , further comprising esterifying the at least one compound with an alcohol to provide an esterified compound.

214 . The process according to claim 213 , further comprising hydrogenating the esterified compound to provide a hydrogenated compound.

215 . (canceled)

216 . (canceled)

217 . (canceled)

218 . (canceled)

219 . (canceled)

220 . (canceled)

221 . (canceled)

222 . The process according to claim 202 , wherein the cyclic alkyl amino carbene ruthenium complex comprises at least one compound selected from Formula B:

wherein

X 1 and X 2 are independently selected from alkoxy and halogen;

R 6 , R 7 and R 8 are independently selected from branched or unbranched alkyl;

R 5 is selected from branched or unbranched alkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted arylalkyl, and optionally substituted heteroarylalkyl, or

R 5 and R 6 are taken together with the carbon to which they are bound to form a 5-, 6-, or 10-membered cycloalkyl or heterocyclyl ring, each of which is optionally substituted;

R 12 is a branched or unbranched alkyl;

R 9 and R 11 are independently selected from hydrogen and branched or unbranched alkyl; and

R 10 is branched or unbranched alkyl.

223 . (canceled)

224 . The process according to claim 222 , wherein when R 11 is hydrogen, R 9 comprises a smaller number of atoms than R 10 .

225 . The process according to claim 222 , wherein when R 11 is hydrogen, R 9 is selected from unbranched alkyl and R 10 is selected from branched alkyl.

226 . The process according to claim 222 , wherein X 1 and X 2 are halogen.

227 . The process according to claim 226 , wherein X 1 and X 2 are chlorine.

228 . The process according to claim 222 , wherein R 12 is a branched C 3 to C 10 alkyl.

229 . The process according to claim 228 , wherein R 12 is isopropyl.

230 . (canceled)

231 . The process according to claim 222 , wherein R 6 , R 7 and R 8 are independently selected from methyl, ethyl, and propyl.

232 . (canceled)

233 . (canceled)

234 . The process according claim 222 , wherein R 11 is hydrogen.

235 . (canceled)

236 . The process according to claim 222 , wherein R 9 is selected from unbranched C 1 to C 10 alkyl.

237 . The process according to claim 236 wherein R 9 is selected from methyl, ethyl, and propyl.

238 . The process according to claim 222 wherein R 10 is selected from branched C 3 to C 10 alkyl.

239 . The process according to claim 238 , wherein R 10 is selected from isopropyl, isobutyl, and tert-butyl.

240 . The process according to claim 222 , wherein R 5 is aryl.

241 . The process according to claim 240 , wherein R 5 is phenyl.

Assignments (4)
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: EVONIK OIL ADDITIVES USA, INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045684/0293 →
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: BP TECHNOLOGY VENTURES INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045688/0600 →
SECURITY INTEREST Recorded Jan 30, 2018
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: BP TECHNOLOGY VENTURES INC.
Reel/Frame 045196/0587 →
SECURITY INTEREST Recorded Mar 18, 2016
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: EVONIK OIL ADDITIVES USA, INC.
Reel/Frame 038146/0859 →